References
1. Health Department-Reported Cases of Multisystem Inflammatory Syndrome
in Children (MIS-C) in the United States | CDC. Accessed
March 1, 2021. https://www.cdc.gov/mis-c/cases/index.html
2. Belhadjer Z, Méot M, Bajolle F, et al. Acute heart failure in
multisystem inflammatory syndrome in children (MIS-C) in the context of
global SARS-CoV-2 pandemic. Circulation . Published online 2020.
doi:10.1161/circulationaha.120.048360
3. Verdoni L, Mazza A, Gervasoni A, et al. An outbreak of severe
Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2
epidemic: an observational cohort study. Lancet . Published online
2020. doi:10.1016/S0140-6736(20)31103-X
4. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P.
Hyperinflammatory shock in children during COVID-19 pandemic.Lancet . 2020;395(10237):1607-1608.
doi:10.1016/S0140-6736(20)31094-1
5. Toubiana J, Poirault C, Corsia A, et al. Kawasaki-like multisystem
inflammatory syndrome in children during the covid-19 pandemic in Paris,
France: prospective observational study. BMJ . Published online
2020. doi:10.1136/bmj.m2094
6. Feldstein LR, Rose EB, Horwitz SM, et al. Multisystem Inflammatory
Syndrome in U.S. Children and Adolescents. N Engl J Med .
Published online 2020. doi:10.1056/nejmoa2021680
7. Lee PY, Day-Lewis M, Henderson LA, et al. Distinct clinical and
immunological features of SARS–CoV-2–induced multisystem inflammatory
syndrome in children. J Clin Invest . Published online 2020.
doi:10.1172/JCI141113
8. Whittaker E, Bamford A, Kenny J, et al. Clinical Characteristics of
58 Children With a Pediatric Inflammatory Multisystem Syndrome
Temporally Associated With SARS-CoV-2. JAMA - J Am Med Assoc .
Published online 2020. doi:10.1001/jama.2020.10369
9. Del Borrello G, Giraudo I, Bondone C, et al. SARS-COV-2-associated
coagulopathy and thromboembolism prophylaxis in children: A
single-center observational study. J Thromb Haemost . Published
online 2020. doi:10.1111/jth.15216
10. Aronoff SC, Hall A, Del Vecchio MT. The Natural History of
SARS-Cov-2 Related Multisystem Inflammatory Syndrome in Children
(MIS-C): A Systematic Review. J Pediatr Infect Dis Soc . Published
online 2020. doi:10.1093/jpids/piaa112
11. Whitworth HB, Sartain SE, Kumar R, et al. Rate of thrombosis in
children and adolescents hospitalized with COVID-19 or MIS-C.Blood . Published online 2021. doi:10.1182/blood.2020010218
12. Panigada M, Bottino N, Tagliabue P, et al. Hypercoagulability of
COVID-19 patients in Intensive Care Unit. A Report of
Thromboelastography Findings and other Parameters of Hemostasis. J
Thromb Haemost . 2020;(April):1738-1742. doi:10.1111/jth.14850
13. Wright FL, Vogler TO, Moore EE, et al. Fibrinolysis Shutdown
Correlation with Thromboembolic Events in Severe COVID-19 Infection.J Am Coll Surg . 2020;231(2):193-203.e1.
doi:10.1016/j.jamcollsurg.2020.05.007
14. Salem N, Atallah B, El Nekidy WS, Sadik ZG, Park WM, Mallat J.
Thromboelastography findings in critically ill COVID-19 patients.J Thromb Thrombolysis . Published online 2020.
doi:10.1007/s11239-020-02300-7
15. Bilaloglu S, Aphinyanaphongs Y, Jones S, Iturrate E, Hochman J,
Berger JS. Thrombosis in Hospitalized Patients with COVID-19 in a New
York City Health System. JAMA - J Am Med Assoc . Published online
2020. doi:10.1001/jama.2020.13372
16. Klok FA, Kruip MJHA, van der Meer NJM, et al. Incidence of
thrombotic complications in critically ill ICU patients with COVID-19.Thromb Res . Published online 2020.
doi:10.1016/j.thromres.2020.04.013
17. Helms J, Tacquard C, Severac F, et al. High risk of thrombosis in
patients with severe SARS-CoV-2 infection: a multicenter prospective
cohort study. Intensive Care Med . Published online 2020.
doi:10.1007/s00134-020-06062-x
18. Hartmann J, Mason D, Achneck H. Thromboelastography (TEG)
Point-of-Care Diagnostic for Hemostasis Management. Point Care .
Published online 2018. doi:10.1097/POC.0000000000000156
19. Harahsheh Y, Duff OC, Ho KM. Thromboelastography predicts
thromboembolism in critically ill coagulopathic patients. Crit
Care Med . Published online 2019. doi:10.1097/CCM.0000000000003730
20. Russell RT, Maizlin II, Vogel AM. Viscoelastic monitoring in
pediatric trauma: a survey of pediatric trauma society members. J
Surg Res . Published online 2017. doi:10.1016/j.jss.2017.03.016
21. Emani S, Sleeper LA, Faraoni D, et al. Thromboelastography Is
Associated With Surrogates for Bleeding After Pediatric Cardiac
Operations. Ann Thorac Surg . Published online 2018.
doi:10.1016/j.athoracsur.2018.04.023
22. Gong C, Yu K, Zhang N, Huang J. Predictive value of
thromboelastography for postoperative lower extremity deep venous
thrombosis in gastric cancer complicated with portal hypertension
patients. Clin Exp Hypertens . Published online 2020.
doi:10.1080/10641963.2020.1836194
23. Information for Healthcare Providers about Multisystem Inflammatory
Syndrome in Children (MIS-C) | CDC. Accessed March 1, 2021.
https://www.cdc.gov/mis-c/hcp/
24. Schulman S, Kearon C, Subcommittee on Control of Anticoagulation of
the Scientific and Standardization Committee of the International
Society on Thrombosis and Haemostasis. Definition of major bleeding in
clinical investigations of antihemostatic medicinal products in
non-surgical patients. J Thromb Haemost . 2005;3(4):692-694.
doi:10.1111/j.1538-7836.2005.01204.x
25. Kaatz S, Ahmad D, Spyropoulos AC, Schulman S. Definition of
clinically relevant non-major bleeding in studies of anticoagulants in
atrial fibrillation and venous thromboembolic disease in non-surgical
patients: Communication from the SSC of the ISTH. J Thromb
Haemost . Published online 2015. doi:10.1111/jth.13140
26. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment,
and long-term management of Kawasaki disease: A scientific statement for
health professionals from the American Heart Association.Circulation . Published online 2017.
doi:10.1161/CIR.0000000000000484
27. Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are
associated with poor prognosis in patients with novel coronavirus
pneumonia. J Thromb Haemost . Published online 2020.
doi:10.1111/jth.14768
28. Biss TT, Brandão LR, Kahr WHA, Chan AKC, Williams S. Clinical
probability score and D-dimer estimation lack utility in the diagnosis
of childhood pulmonary embolism. J Thromb Haemost . Published
online 2009. doi:10.1111/j.1538-7836.2009.03572.x
29. Al-Ghafry M, Aygun B, Appiah-Kubi A, et al. Are children with
SARS-CoV-2 infection at high risk for thrombosis? Viscoelastic testing
and coagulation profiles in a case series of pediatric patients.Pediatr Blood Cancer . Published online 2020.
doi:10.1002/pbc.28737
30. Hranjec T, Estreicher M, Rogers B, et al. Integral Use of
Thromboelastography With Platelet Mapping to Guide Appropriate
Treatment, Avoid Complications, and Improve Survival of Patients With
Coronavirus Disease 2019–Related Coagulopathy. Crit Care Explor .
2020;2(12):e0287. doi:10.1097/cce.0000000000000287
31. The Lancet Haematology. COVID-19 coagulopathy: an evolving story.Lancet Haematol . Published online 2020.
doi:10.1016/S2352-3026(20)30151-4
32. Pons S, Fodil S, Azoulay E, Zafrani L. The vascular endothelium: The
cornerstone of organ dysfunction in severe SARS-CoV-2 infection.Crit Care . Published online 2020. doi:10.1186/s13054-020-03062-7
33. Kuhle S, Male C, Mitchell L. Developmental hemostasis: Pro- and
anticoagulant systems during childhood. Semin Thromb Hemost .
Published online 2003. doi:10.1055/s-2003-42584
34. Lam WA, Chaudhuri O, Crow A, et al. Mechanics and contraction
dynamics of single platelets and implications for clot stiffening.Nat Mater . Published online 2011. doi:10.1038/nmat2903
35. Hottz ED, Azevedo-Quintanilha IG, Palhinha L, et al. Platelet
activation and platelet-monocyte aggregate formation trigger tissue
factor expression in patients with severe COVID-19. Blood .
Published online 2020. doi:10.1182/blood.2020007252
36. Allegra A, Innao V, Allegra AG, Musolino C. Coagulopathy and
thromboembolic events in patients with SARS-CoV-2 infection:
pathogenesis and management strategies. Ann Hematol . Published
online 2020. doi:10.1007/s00277-020-04182-4
37. Manne BK, Denorme F, Middleton EA, et al. Platelet gene expression
and function in patients with COVID-19. Blood . Published online
2020. doi:10.1182/blood.2020007214
38. Al-Samkari H, Karp Leaf RS, Dzik WH, et al. COVID-19 and
coagulation: Bleeding and thrombotic manifestations of SARS-CoV-2
infection. Blood . Published online 2020.
doi:10.1182/BLOOD.2020006520
39. Henderson LA, Canna SW, Friedman KG, et al. American College of
Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in
Children Associated With SARS–CoV-2 and Hyperinflammation in Pediatric
COVID-19: Version 1. Arthritis Rheumatol . Published online 2020.
doi:10.1002/art.41454
40. Elias MD, McCrindle BW, Larios G, et al. Management of Multisystem
Inflammatory Syndrome in Children Associated With COVID-19: A Survey
From the International Kawasaki Disease Registry. CJC Open .
Published online 2020. doi:10.1016/j.cjco.2020.09.004
41. Goldenberg NA, Sochet A, Albisetti M, et al. Consensus-based
clinical recommendations and research priorities for anticoagulant
thromboprophylaxis in children hospitalized for COVID-19–related
illness. J Thromb Haemost . Published online 2020.
doi:10.1111/jth.15073